This compound is a chemical intermediate used in the synthesis of alogliptin benzoate impurities. It features a pyrimidinedione ring with chloro, ethyl, and benzonitrile substituents.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1430222-06-2
Alogliptin Impurity 07
pharmaceutical intermediate
2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]benzonitrile
pharmaceutical intermediate
2-[[6-[(3R)-3-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile
pharmaceutical intermediate
1alpha-Hydroxy VD4
pharmaceutical intermediate
(2R,3S,4S)-2,3,4-Tris(benzyloxy)-4-(4-((benzyloxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-(4-methylpiperazin-1-yl)butan-1-one oxalate
pharmaceutical intermediate
Ethyl 2-(2-benzyl-3-hydroxypropanamido)acetate
pharmaceutical intermediate
2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-benzonitrile-d3
pharmaceutical raw material
2-((6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)methyl)benzonitrile
research compound
2-[(6-chloro-3-ethyl-2,4-dioxopyrimidin-1-yl)methyl]benzonitrile
OLHHKMKGYKDSCX-UHFFFAOYSA-N
CCN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)Cl